Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 315

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

139	NVLX NEWS OUT:	stocklegend	01/13/2014 9:38:48 AM
138	NVLX~ Up Trend Galore!	stocklegend	01/13/2014 9:11:37 AM
137	NVLX~	stocklegend	01/13/2014 8:50:13 AM
136	Nuvilex Listed in Forbes Article on Biotech	stocklegend	12/20/2013 3:25:32 PM
135	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	12/20/2013 3:13:04 PM
134	$NVLX Nuvilex COO Talks About Companys	stocklegend	12/20/2013 2:19:50 PM
133	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	12/20/2013 1:52:41 PM
132	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	12/20/2013 1:38:48 PM
131	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	12/20/2013 1:15:52 PM
130	$NVLX Nuvilex Completes Acquisition of	stocklegend	12/20/2013 12:53:16 PM
129	$NVLX Nuvilex Completes Acquisition of	stocklegend	12/20/2013 12:52:02 PM
128	NVLX news:	stocklegend	12/20/2013 12:24:45 PM
127	$NVLX Nuvilex Accelerates Development of	stocklegend	12/20/2013 12:21:15 PM
126	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	12/20/2013 11:55:26 AM
125	Nuvilex Ahead of the Curve on Cannabidiol as FDA	stocklegend	12/20/2013 11:39:00 AM
124	$NVLX Investors Confidently Back Nuvilex's	stocklegend	12/20/2013 11:02:20 AM
123	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	12/20/2013 10:35:41 AM
121	After Pancreatic Cancer, Eli Lilly and Nuvilex	stocklegend	12/20/2013 10:25:08 AM
120	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	12/20/2013 9:51:58 AM
119	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	12/20/2013 9:25:18 AM
118	Nuvilex Begins Making Moves at its Medical	stocklegend	12/20/2013 9:08:55 AM
117	Nuvilex's Medical Marijuana Subsidiary Appoints	stocklegend	12/20/2013 8:57:36 AM
116	$NVLX Nuvilex Accelerates Development of	stocklegend	12/19/2013 3:35:05 PM
115	$NVLX Nuvilex Completes Acquisition of	stocklegend	12/19/2013 3:13:24 PM
114	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	12/19/2013 2:35:25 PM
113	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	12/19/2013 2:07:32 PM
112	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	12/19/2013 1:48:19 PM
111	$NVLX Nuvilex COO Talks About Companys	stocklegend	12/19/2013 1:24:39 PM
110	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	12/19/2013 12:49:08 PM
109	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	12/19/2013 12:33:40 PM
108	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	12/19/2013 12:02:53 PM
107	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	12/19/2013 11:36:47 AM
106	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	12/19/2013 11:10:29 AM
105	NVLX News Out:	stocklegend	12/19/2013 10:26:09 AM
104	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	12/19/2013 10:24:49 AM
103	$NVLX - Nuvilex Restructures its Operations to	stocklegend	12/19/2013 10:06:56 AM
102	$NVLX - Nuvilex Restructures to Focus on	stocklegend	12/19/2013 9:29:30 AM
101	Nuvilex Contracts with Inno Biologics to Clone	stocklegend	12/19/2013 9:17:36 AM
100	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	12/19/2013 8:48:26 AM
99	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	12/18/2013 2:22:14 PM
98	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	12/18/2013 1:52:45 PM
97	Nuvilex Announces Cloning of Cells for Phase 3	stocklegend	12/18/2013 1:28:59 PM
96	$NVLX Nuvilex Completes Acquisition of	stocklegend	12/18/2013 1:16:18 PM
95	$NVLX Nuvilex Accelerates Development of	stocklegend	12/18/2013 12:44:59 PM
94	Nuvilex's Acquisition of Diabetes Rights Should	stocklegend	12/18/2013 12:26:46 PM
93	$NVLX Nuvilex Ahead of the Curve on	stocklegend	12/18/2013 12:01:07 PM
92	$NVLX Investors Confidently Back Nuvilex's	stocklegend	12/18/2013 11:48:52 AM
91	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	12/18/2013 11:37:29 AM
90	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	12/18/2013 11:27:08 AM
89	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	12/18/2013 11:07:55 AM

Newer

Older

Recent Articles

• Eastman Kodak's Strategic Pension Plan Move and Market Impact
• HPH Announces Leadership Transition and Future Focus
• SpaceX to Launch NASA's Dragonfly Mission to Titan
• Clairvest's New Partnership with Redstone Food Group
• Automotive Properties REIT Acquires Key Montreal Rental Properties
• Tim Draper Enthusiastically Predicts Bitcoin's Striking Rise
• Hennessy Advisors' ESG ETF to Transfer Listings to Nasdaq
• Agora, Inc. Sees Strategic Shifts Amid Financial Adjustments
• Hesai Group Announces Impressive Q3 2024 Financial Growth
• Creative Global Technology Holdings' Upcoming IPO Details
• Central Garden & Pet Reports Q4 Earnings: Key Insights Revealed
• Analyzing Woodward's Q4 Earnings and Future Outlook
• Blue Bird's Financial Performance in the Latest Earnings Report
• Central Garden & Pet Reports Strong Q4 Earnings Performance
• Central Garden & Pet's Strong Q4 Earnings Highlights
• Enanta Pharma's Earnings Report Highlights for Investors in 2024
• Woodward Reports Strong Q4 Earnings, Offers Positive Guidance Ahead
• Blue Bird's Fourth Quarter Earnings: Key Insights and Analysis
• Leslie's Performance in Q4: Key Insights and Future Prospects
• Exploring Central Garden & Pet's Recent Earnings Performance
• Insights into Enanta Pharma's Q4 Earnings Performance
• Blue Bird's Q4 Earnings Report Reveals Key Insights
• NHTSA Stands Firm on New Emergency Braking Rule for Vehicles
• Columbia Financial Appoints Matthew Smith as New COO
• Impact of Treasury Picks on Markets and Emerging Economies
• Market Reactions: Insights on Zoom, Agilent, HanesBrands, Kohl's
• Zoom Communications Enhances Forecast Following Strong Q3 Results
• Leadership Transition at Kohl's: Kingsbury's Departure Announced
• Tempest Therapeutics to Showcase Innovations at Key Conference
• Travere Therapeutics Announces Key Upcoming Investor Conferences
• Tesla Stock Faces Market Challenges Amid California Proposals
• Chegg Inc. Experience Stock Surge Following Debt Repurchase Deal
• Zoom Communications Turns a Profit with Impressive Q3 Earnings
• First Capital, Inc. Declares New Quarterly Dividend for Investors
• Columbia Financial Welcomes New COO Matthew Smith Amid Changes
• Universal Health Realty Income Trust Boosts Quarterly Dividend
• Amazon Strengthens AI Alliances with Major Investment in Anthropic
• Enanta Pharma's Q4 Earnings Exceed Expectations, Highlights Ahead
• Woodward's Q4 Earnings Highlights and Future Outlook for Investors
• Blue Bird's Q4 Earnings: Performance Review and Insights
• Central Garden & Pet: Analyzing Quarterly Earnings Results
• Central Garden & Pet Q4 Earnings Show Surprising Results
• Semtech's Q3 Earnings Report Shows Promising Growth
• LanzaTech Expands Board for Future Growth with Energy Expert
• Zimmer Biomet Secures FDA Approval for Innovative Knee Implant
• Remitly to Showcase Innovations at Upcoming TMT Summit
• Dana Incorporates Leadership Change Amid Strategic Transformation
• Lexicon Pharmaceuticals Announces Upcoming December Investor Events
• Gaming and Leisure Properties, Inc. Announces Q4 2024 Dividend
• NJR Clean Energy Ventures Finalizes $132.5 Million Solar Sale